International Journal of Endocrinology and Metabolism

Published by: Kowsar

Oxidative Stress and Raloxifene

Gurkan Akgol 1 , Arif Gulkesen 2 and Salih Ozgocmen 3 , *
Authors Information
1 Bingol State Hospital, PMR Clinic, Bingol, Turkey
2 Firat University, Faculty of Medicine, Deptartment PMR, Elazig, Turkey
3 Erciyes University, Faculty of Medicine, Deptartment PMR, Division of Rheumatology, Kayseri, Turkey
Article information
  • International Journal of Endocrinology and Metabolism: June 01, 2012, 10 (3); 577-578
  • Published Online: June 30, 2012
  • Article Type: Letter
  • Received: April 28, 2012
  • Revised: April 30, 2012
  • Accepted: April 30, 2012
  • DOI: 10.5812/ijem.5341

To Cite: Akgol G, Gulkesen A, Ozgocmen S. Oxidative Stress and Raloxifene, Int J Endocrinol Metab. 2012 ;10(3):577-578. doi: 10.5812/ijem.5341.

Copyright © 2012, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Footnotes
References
  • 1. Saito O, Saito T, Asakura S, Akimoto T, Inoue M, Ando Y, et al. Effects of raloxifene on bone metabolism in hemodialysis patients with type 2 diabetes. Int J Endocrinol Metab. 2012; 10(2): 464-9[DOI]
  • 2. Libetta C, Sepe V, Esposito P, Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem. 2011; 44(14-15): 1189-98[DOI][PubMed]
  • 3. Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011; 11(4): 330-6[DOI][PubMed]
  • 4. Ozgocmen S, Kaya H, Fadillioglu E, Yilmaz Z. Effects of calcitonin, risedronate, and raloxifene on erythrocyte antioxidant enzyme activity, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Arch Med Res. 2007; 38(2): 196-205[DOI][PubMed]
  • 5. Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem. 2007; 295(1-2): 45-52[DOI][PubMed]
  • 6. Kaya H, Ozkaya O, Sezik M, Arslanoglu E, Yilmaztepe A, Ulukaya E. Effects of raloxifene on serum malondialdehyde, erythrocyte superoxide dismutase, and erythrocyte glutathione peroxidase levels in healthy postmenopausal women. Maturitas. 2005; 50(3): 182-8[DOI][PubMed]
  • 7. Mackinnon ES, Rao AV, Josse RG, Rao LG. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. Osteoporos Int. 2011; 22(4): 1091-101[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments